E2F1 suppresses skin carcinogenesis via the ARF-p53 pathway

Oncogene

Volumn 25, Issue 6, 2006, Pages 867-876

  Russell, J L ^a,b   Weaks, R L ^a   Berton, T R ^a   Johnson, D G ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

E2F; p19ARF; p21; p53

Indexed keywords

ARF PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1; PROTEIN P19; PROTEIN P53; RAS PROTEIN; TRANSCRIPTION FACTOR E2F1; TUMOR PROMOTER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER MODEL; CONTROLLED STUDY; EPIDERMIS; GENE EXPRESSION; GENE INACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; SKIN CARCINOGENESIS; TRANSGENE; TRANSGENIC MOUSE; TUMOR PROMOTION;

ANIMALS; CARCINOGENS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASE INHIBITOR P21; E2F1 TRANSCRIPTION FACTOR; GENES, TUMOR SUPPRESSOR; HYPERPLASIA; MICE; MICE, TRANSGENIC; PROMOTER REGIONS (GENETICS); SIGNAL TRANSDUCTION; SKIN; SKIN NEOPLASMS; TETRADECANOYLPHORBOL ACETATE; TUMOR SUPPRESSOR PROTEIN P14ARF; TUMOR SUPPRESSOR PROTEIN P53; ULTRAVIOLET RAYS;

ANIMALIA; MUS MUSCULUS;

EID: 32544444623     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209120     Document Type: Article

References (67)

1. Barak Y, Juven T, Haffner R, Oren M. (1993). EMBO J 12: 461-468.
2. Bates S, Phillips AC, Clark PA, Stott F, Peters G, Ludwig RL et al. (1998). Nature 395: 124-125.
3. Blattner C, Sparks A, Lane D. (1999). Mol Cell Biol 19: 3704-3713.
4. Conner EA, Lemmer ER, Omori M, Wirth PJ, Factor VM, Thorgeirsson SS. (2000). Oncogene 19: 5054-5062.
5. Conti CJ. (1994) In: Sundberg JP (ed). Handbook of Mouse Mutations with Skin and Hair Abnormalities. Boca Raton, FL: CRC, pp 39-46.
6. de Stanchina E, McCurrach ME, Zindy F, Shieh SY, Ferbeyre G, Samuelson AV et al. (1998). Genes Dev 12: 2434-2442.
7. DeGregori J, Leone G, Miron A, Jakoi L, Nevins JR. (1997). Proc Natl Acad Sci USA 94: 7245-7250.
8. Denchi EL, Attwooll C, Pasini D, Helin K. (2005). Mol Cell Biol 25: 2660-2672.
9. Dimri GP, Itahana K, Acosta M, Campisi J. (2000). Mol Cell Biol 20: 273-285.
10. Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery Jr CA, Butel JS et al. (1992). Nature 356: 215-221.
11. Eymin B, Karayan L, Seite P, Brambilla C, Brambilla E, Larsen CJ et al. (2001). Oncogene 20: 1033-1041.
12. Fischer SM, O'Connell JF, Conti CJ, Tacker KC, Fries JW, Patrick KE et al. (1987). Carcinogenesis 8: 421-424.
13. Gorgoulis VG, Zacharatos P, Mariatos G, Kotsinas A, Bouda M, Kletsas D et al. (2002). J Pathol 198: 142-156.
14. Greenhalgh DA, Wang XJ, Donehower LA, Roop DR. (1996). Cancer Res 56: 4413-4423.
15. Irwin M, Marin MC, Phillips AC, Seelan RS, Smith DI, Liu W et al. (2000). Nature 407: 645-648.
16. Johnson DG, Cress WD, Jakoi L, Nevins JR. (1994a). Proc Natl Acad Sci USA 91: 12823-12827.
17. Johnson DG, Ohtani K, Nevins JR. (1994b). Genes Dev 8: 1514-1525.
18. Johnson DG, Schwarz JK, Cress WD, Nevins JR. (1993). Nature 365: 349-352.
19. Kamijo T, Zindy F, Roussel MF, Quelle DE, Downing JR, Ashmun RA et al. (1997). Cell 91: 649-659.
20. Kemp CJ, Donehower LA, Bradley A, Balmain A. (1993). Cell 74: 813-822.
21. Khan SH, Moritsugu J, Wahl GM. (2000). Proc Natl Acad Sci USA 97: 3266-3271.
22. Kowalik TF, DeGregori J, Schwarz JK, Nevins JR. (1995). J Virol 69: 2491-2500.
23. Leder A, Kuo A, Cardiff RD, Sinn E, Leder P. (1990). Proc Natl Acad Sci USA 87: 9178-9182.
24. Lin AW, Barradas M, Stone JC, van Aelst L, Serrano M, Lowe SW. (1998). Genes Dev 12: 3008-3019.
25. Lin AW, Lowe SW. (2001). Proc Natl Acad Sci USA 98: 5025-5030.
26. Lin WC, Lin FT, Nevins JR. (2001). Genes Dev 15: 1833-1844.
27. Martelli F, Hamilton T, Silver DP, Sharpless NE, Bardeesy N, Rokas M et al. (2001). Proc Natl Acad Sci USA 98: 4455-4460.
28. Missero C, Di Cunto F, Kiyokawa H, Koff A, Dotto GP. (1996). Genes Dev 10: 3065-3075.
29. Mitchell DL, Greinert R, de Gruijl FR, Guikers KL, Breitbart EW, Byrom M et al. (1999). Cancer Res 59: 2875-2884.
30. Moroni MC, Hickman ES, Denchi EL, Caprara G, Colli E, Cecconi F et al. (2001). Nat Cell Biol 3: 552-558.
31. Nahle Z, Polakoff J, Davuluri RV, McCurrach ME, Jacobson MD, Narita M et al. (2002). Nat Cell Biol 4: 859-864.
32. Palmero I, Pantoja C, Serrano M. (1998). Nature 395: 125-126.
33. Pan H, Yin C, Dyson NJ, Harlow E, Yamasaki L, Dyke TV. (1998). Mol Cell Biol 2: 283-292.
34. Paramio JM, Segrelles C, Ruiz S, Martin-Caballero J, Page A, Martinez J et al. (2001). J Biol Chem 276: 44203-44211.
35. Pierce AM, Fischer SM, Conti CJ, Johnson DG. (1998a). Oncogene 16: 1267-1276.
36. Pierce AM, Gimenez-Conti IB, Schneider-Broussard R, Martinez LA, Conti CJ, Johnson DG. (1998b). Proc Natl Acad Sci USA 95: 8858-8863.
37. Pierce AM, Schneider-Broussard R, Gimenez-Conti IB, Russell JL, Conti CJ, Johnson DJ. (1999). Mol Cell Biol 19: 6408-6414.
38. Powers JT, Hong S, Mayhew CN, Rogers PM, Knudsen ES, Johnson DG. (2004). Mol Cancer Res 2: 203-214.
39. Prives C. (1998). Cell 95: 5-8.
40. Qin X-Q, Livingston Jr WGK, Adams PD. (1994). Proc Natl Acad Sci USA 91: 10918-10922.
41. Quintanilla M, Brown K, Ramsden M, Balmain A. (1986). Nature 322: 78-80.
42. Ramirez A, Bravo A, Jorcano JL, Vida M. (1994). Differentiation 58: 53-64.
43. Rizos H, Woodruff S, Kefford RF. (2005). Cell Cycle 4: 597-603.
44. Rogoff HA, Pickering MT, Debatis ME, Jones S, Kowalik TF. (2002). Mol Cell Biol 22: 5308-5318.
45. Rogoff HA, Pickering MT, Frame FM, Debatis ME, Sanchez Y, Jones S et al. (2004). Mol Cell Biol 24: 2968-2977.
46. Rounbehler RJ, Rogers PM, Conti CJ, Johnson DG. (2002). Cancer Res 62: 3276-3281.
47. Rounbehler RJ, Schneider-Broussard R, Conti CJ, Johnson DG. (2001). Oncogene 20: 5341-5349.
48. Russell JL, Powers JT, Rounbehler RJ, Rogers PM, Conti CJ, Johnson DG. (2002). Mol Cell Biol 22: 1360-1368.
49. Saito M, Helin K, Valentine MB, Griffith BB, Willman CL, Harlow E et al. (1995). Genomics 25: 130-138.
50. Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW. (1997). Cell 88: 593-602.
51. Sherr CJ. (2000). Cancer Res 60: 3689-3695.
52. Suganuma M, Fujiki H, Suguri H, Yoshizawa S, Hirota M, Nakayasu M et al. (1988). Proc Natl Acad Sci USA 85: 1768-1771.
53. Tolbert D, Lu X, Yin C, Tantama M, Van Dyke T. (2002). Mol Cell Biol 22: 370-377.
54. Tsai KY, Hu Y, Macleod KF, Crowley D, Yamasaki L, Jacks T. (1998). Mol Cell 2: 293-304.
55. Tsai KY, MacPherson D, Rubinson DA, Crowley D, Jacks T. (2002). Curr Biol 12: 159-163.
56. Vorburger SA, Pataer A, Yoshida K, Barber GN, Xia W, Chiao P et al. (2002). Oncogene 21: 6278-6288.
57. Wang D, Russell J, Xu H, Johnson DG. (2001). Mol Carcinog 31: 90-100.
58. Wang D, Russell JL, Johnson DG. (2000). Mol Cell Biol 20: 3417-3424.
59. Wei W, Hemmer RM, Sedivy JM. (2001). Mol Cell Biol 21: 6748-6757.
60. Wu X, Bayle JH, Olson D, Levine AJ. (1993). Genes Dev 7: 1126-1132.
61. Wu X, Levine AJ. (1994). Proc Natl Acad Sci USA 91: 3602-3606.
62. Xu G, Livingston DM, Krek W. (1995). Proc Natl Acad Sci USA 92: 1357-1361.
63. Yamasaki L, Jacks T, Bronson R, Goillot E, Harlow E, Dyson NJ. (1996). Cell 85: 537-548.
64. Yuspa SH. (1998). J Dermatol Sci 17: 1-7.
65. Zhu JW, Field SJ, Gore L, Thompson M, Yang H, Fujiwara Y et al. (2001). Mol Cell Biol 21: 8547-8564.
66. Ziegler A, Jonason AS, Leffell DJ, Simon JA, Sharma HW, Kimmelman J et al. (1994). Nature 372: 773-776.
67. Zindy F, Eischen CM, Randle DH, Kamijo T, Cleveland JL, Sherr CJ et al. (1998). Genes Dev 12: 2424-2433.